2028년까지 유럽 색전술제 시장 예측 - 제품별(코일, 플러그, 비드/입자, 분리형 풍선, 접착제, 스폰지, 액체 색전제, 경화제, 침전제 및 기타), 용도별(종양학, 신경학) 코로나19 영향 및 지역 분석 , 비뇨기과, 심장학, 말초 혈관 질환 및 기타) 및 최종 사용자(병원, 심장 센터, 외래 수술 센터 및 기타)

시장 소개

유럽 색전술제 시장에는 독일, 프랑스, 영국, 스페인, 이탈리아 및 기타 유럽 지역. 유럽은 전 세계 색전술제 시장에서 중요한 위치를 차지하고 있으며 예측 기간 동안 강력한 성장률을 기록할 것으로 추정됩니다. 이 지역의 시장 성장은 인구 노령화, 암 및 뇌동맥류의 유병률 증가, 제품 출시 횟수 증가로 인해 유럽에서 이 시장 성장을 이끄는 주요 요인이 될 것으로 예상됩니다. 뇌동맥류는 출혈성 뇌졸중으로 알려진 뇌 출혈로 이어질 수도 있습니다. 최근 독일에서 뇌졸중의 유병률이 기록되었습니다. 유럽 뇌졸중 연합(Stroke Alliance for Europe)을 위해 킹스 칼리지 런던(King\'s College London)이 실시한 유럽 뇌졸중 부담(The Burden of Stroke in Europe) 보고서에 발표된 데이터에 따르면 뇌졸중 발병률은 약 88,922건으로 독일에서 매년 인구 100,000명당 51.7건의 뇌졸중이 발생합니다. 독일의 뇌졸중 유병률은 약 526,774명으로 인구 100,000명당 뇌졸중 발생 건수는 338.5건입니다. 또한 우리나라는 뇌졸중으로 인한 사망률이 상당히 높습니다. 즉, 연간 뇌졸중으로 인한 사망자 수는 75,861명입니다. 추산에 따르면 독일의 뇌졸중 발병률은 2035년 말까지 30% 증가할 것으로 예상됩니다. 또한 2035년까지 유병률과 사망률은 각각 19%와 40%로 증가할 것으로 예상됩니다. 일반적인 위험 요소 중 일부 뇌졸중의 원인으로는 고혈압, 흡연, 높은 콜레스테롤, 혈당 상승 등이 있습니다. 국내 시장에서도 혁신적인 제품 출시에 주력하고 있다. 이러한 발전은 또한 시장 성장을 가속화할 것으로 예상됩니다. 예를 들어, 2020년 4월 신경혈관 질환에 대한 혁신적인 기술의 선구자인 Phenox GmbH는 새로운 p64MW 흐름 변조 장치를 출시했습니다. 차세대 스텐트형 장치인 p64 MW 흐름 변조 장치는 동맥류로부터 혈액의 흐름을 전환하도록 고안되었습니다.

유럽, 이탈리아, 스페인 및 프랑스에서는 코로나19 확진자가 가장 많이 보고됐다. 유럽질병예방통제센터(ECDC)에 따르면 2021년 6월 현재까지 유럽 내 코로나19로 인한 사망자는 736,553명이다. 유럽 전역의 국가에서는 올해 초 발병을 성공적으로 완화한 후 코로나19 사례가 다시 증가하는 것을 목격하고 있습니다. 많은 국가에서 대유행의 첫 번째 물결 동안 보고된 일일 사례 수보다 매일 더 많은 사례가 보고되고 있습니다. ECDC에 따르면 영국, 스페인, 이탈리아, 아일랜드에서는 폐쇄가 다시 도입되고 있습니다. 또한, 많은 국가 정부는 세포 치료, 유전자 치료 및 재생 의학 역량을 강화하기 위해 노력하고 있습니다. 또한 영국에서는 암 및 신경 질환에 대한 관행이 변경되었습니다. 코로나19의 증가로 인해 의료인력의 다양화와 중증환자 치료에 집중하게 되면서 질병의 진단과 치료에 영향을 미치게 되었습니다. 많은 연구 기관은 코로나19 연구에 더 집중하고 있으며 바이러스를 더 잘 이해하기 위해 열심히 노력하고 있습니다. 유럽신경학회(EAN)는 질병의 신경학적 징후를 더 잘 이해하기 위해 코로나19 환자의 신경학적 증상에 대한 조사를 시작했습니다. 따라서 SARS-CoV-2에 대한 관심이 높아지면서 지난 2년 동안 유럽 색전제 시장 성장이 제한되었습니다.

시장 개요 및 역학

유럽 색전술제 시장은 2021년 7억 9,579만 달러에서 2028년 12억 8,295만 달러로 성장할 것으로 예상됩니다. 2021년부터 2028년까지 CAGR 7.1%로 성장할 것으로 예상됩니다. 2021년 9월 메드트로닉 색전술 장치는 분리된 코일을 리콜하는 또 다른 클래스 I 리콜과 충돌했습니다. FDA는 59건의 오작동, 10건의 심각한 부상, 2건의 사망에 대한 보고를 받은 후 뇌 동맥류 치료를 위한 메드트로닉의 Pipeline Flex 색전술 장치에 대한 또 다른 리콜을 1급 사건으로 분류했습니다. 2021년 7월 Terumo는 마이크로카테터와 호환되고 최대 직경 8mm의 동맥을 폐색할 수 있는 최초이자 유일한 플러그인 새로운 AZUR 혈관 플러그 및 PG Pro 주변 마이크로카테터 색전술 시스템을 출시합니다. Terumo의 광범위한 색전술 포트폴리오에 새로 추가된 제품은 말초 혈관계 동맥에서 혈류를 제한하거나 중단하는 데 사용하는 것이 좋습니다. 또한, 2021년 5월 Shanghai MicroPort NeuroTech Co., Ltd.는 Numen 코일 색전술 시스템(Numen) 및 Numen FR 코일 분리 시스템(Numen FR)에 대해 유럽 연합으로부터 CE 승인을 받았습니다. 이는 두개내 동맥류 치료를 위한 코일 색전술 절차에 사용됩니다. 이 회사는 뇌혈관 및 신경 중재에 대한 혁신적인 솔루션을 개발하기 위한 연구 개발 활동에 중점을 두고 있습니다. 또한 2020년 12월에는 테루모 코퍼레이션(Terumo Corporation)이 낭내 동맥류 치료 장치인 WEB Embolization System(일본 제품명: Woven EndoBridge Device)을 일본에서 출시했습니다. WEB 장치는 혁신적인 낭내 흐름 방해 장치이며 뇌 동맥류 사례에 대한 새로운 치료 옵션을 제공합니다. 현대 기술을 기반으로 한 이러한 발전은 향후 유럽 색전술제 시장에 새로운 미래 트렌드를 도입할 가능성이 높습니다.

주요 시장 부문

제품을 기준으로 시장은 코일, 비드/입자, 플러그, 분리형 풍선, 접착제, 스펀지, 액체 색전제, 경화제, 침전제, 다른 사람. 비드/입자 부문은 2020년 시장에서 가장 큰 점유율을 차지했습니다. 코일을 기준으로 시장은 분리형 코일과 푸시형 코일로 구분됩니다. 푸시형 코일 부문은 2020년 시장에서 가장 큰 점유율을 차지했습니다. 비드/입자를 기준으로 시장은 구형과 비구형으로 구분됩니다. 밀어 넣을 수 있는 비구형 부문은 2020년 시장에서 가장 큰 점유율을 차지했습니다. 응용 분야에 따라 시장은 신경학, 종양학, 심장학, 말초 혈관 질환 등으로 분류됩니다. 2020년에는 종양학 부문이 시장에서 가장 큰 점유율을 차지할 가능성이 높습니다. 최종 사용자별 색전제 시장은 병원, 외래 수술 센터, 심장 센터 등으로 분류됩니다. 병원 부문은 2020년 시장에서 가장 큰 점유율을 차지했습니다.

주요 출처 및 상장 회사

유럽 색전술제 시장에 대한 이 보고서를 준비하기 위해 참조된 몇 가지 주요 1차 및 2차 소스로는 회사 웹사이트, 연례 보고서, 재무 보고서, 국가 정부 문서, 통계 데이터베이스 등이 있습니다. . 보고서에 나열된 주요 회사는 Abbott입니다. 보스턴 사이언티픽 코퍼레이션; 쿡 메디컬 LLC; DePuy 합성; 카네카 주식회사; 메드트로닉; 메리트 메디컬 시스템즈(Merit Medical Systems Inc); Penumbra, Inc.; 스트라이커 코퍼레이션; 및 기타 Terumo Corporation.

구매 이유 보고서

유럽 색전술제 시장 환경을 이해하고 강력한 수익을 보장할 가능성이 가장 높은 시장 부문을 식별합니다.
유럽 색전술제 시장의 끊임없이 변화하는 경쟁 환경을 이해하여 경쟁에서 앞서 나가세요
M&A 및 파트너십을 효율적으로 계획하세요 가장 유망한 예상 판매가 있는 시장 부문을 식별하여 유럽 색전술제 시장에서 거래
유럽 색전술을 형성하는 다양한 부문의 시장 성과에 대한 통찰력 있고 포괄적인 분석을 통해 지식이 풍부한 비즈니스 결정을 내리는 데 도움이 됩니다. 에이전트 시장
2021~2028년 유럽 지역의 다양한 부문별 시장 수익 예측을 얻으세요.

유럽 색전증 치료제 시장 세분화

제품별

작성자 애플리케이션

작성자 최종 사용자

병원
심장 센터
외래 수술 센터
기타

국가별

회사 프로필

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Europe Embolization Agents Market – By Product

1.3.2 Europe Embolization Agents Market – By Application

1.3.3 Europe Embolization Agents Market – By End User

1.3.4 Europe Embolization Agents Market – By Country

2. Europe Embolization Agents Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Europe Embolization Agents Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 Europe– PEST Analysis

4.3 Experts Opinion

5. Europe Embolization Agents Market– Key Market Dynamics

5.1 Market Drivers

5.1.1 Growing in the Incidence of Tumors and Aneurysms

5.1.1 Rise Incidence of Hypertension, Obesity, Smoking, and Alcoholism

5.2 Market Restraints

5.2.1 Huge Cost of Embolization Agents

5.3 Market Opportunities

5.3.1 Rising Geriatric Population Base

5.4 Future Trends

5.4.1 Technological Advancements in Embolization Products and Procedures

5.5 Impact analysis

6. Embolization Agents Market – Europe Analysis

6.1 Europe Embolization Agents Market Revenue Forecast and Analysis

7. Europe Embolization Agents Market Analysis – By Product

7.1 Overview

7.2 Europe Embolization Agents Market Revenue Share, by Product (2021 and 2028)

7.3 Coils

7.3.1 Overview

7.3.2 Coils: Europe Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

7.3.2.1 Detachable Coils

7.3.2.1.1 Detachable Coil Market Revenue and Forecast to 2028 (US$ Mn)

7.3.2.1.2 Detachable Coil Market Revenue and Forecasts to 2028 (US$ Mn)

7.3.2.2 Pushable Coils

7.3.2.2.1 Pushable Coil Market Revenue and Forecast to 2028 (US$ Mn)

7.3.2.2.2 Pushable Coil Market Revenue and Forecasts to 2028 (US$ Mn)

7.4 Beads/Particles

7.4.1 Overview

7.4.2 Beads/Particles: Europe Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

7.4.2.1 Spherical

7.4.2.1.1 Spherical Market Revenue and Forecast to 2028 (US$ Mn)

7.4.2.1.2 Spherical Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.2.2 Non-Spherical

7.4.2.2.1 Non-Spherical Market Revenue and Forecast to 2028 (US$ Mn)

7.4.2.2.2 Non-Spherical Market Revenue and Forecasts to 2028 (US$ Mn)

7.5 Plugs

7.5.1 Overview

7.5.2 Plugs: Europe Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

7.6 Detachable Balloons

7.6.1 Overview

7.6.2 Detachable Balloons: Europe Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

7.7 Glue

7.7.1 Overview

7.7.2 Glue: Europe Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

7.8 Sponge

7.8.1 Overview

7.8.2 Sponge: Europe Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

7.9 Liquid Embolics

7.9.1 Overview

7.9.2 Liquid Embolics: Europe Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

7.10 Sclerosants

7.10.1 Overview

7.10.2 Sclerosants: Europe Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

7.11 Precipitating Agents

7.11.1 Overview

7.11.2 Precipitating Agents: Europe Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

7.12 Others

7.12.1 Overview

7.12.2 Others: Europe Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

8. Europe Embolization Agents Market Analysis – By Application

8.1 Overview

8.2 Europe Embolization Agents Market, by Application 2021 & 2028 (%)

8.3 Oncology

8.3.1 Overview

8.3.2 Oncology: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Neurology

8.4.1 Overview

8.4.2 Neurology: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

8.5 Urology

8.5.1 Overview

8.5.2 Urology: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

8.6 Cardiology

8.6.1 Overview

8.6.2 Cardiology: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

8.7 Peripheral Vascular Diseases

8.7.1 Overview

8.7.2 Peripheral Vascular Diseases: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

8.8 Others

8.8.1 Overview

8.8.2 Others: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

9. Europe Embolization Agents Market Analysis – By End User

9.1 Overview

9.2 Europe Embolization Agents Market Revenue Share, By End User (2021 and 2028)

9.3 Hospitals

9.3.1 Overview

9.3.2 Hospitals: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

9.4 Cardiac Centers

9.4.1 Overview

9.4.2 Cardiac Centers: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

9.5 Ambulatory Surgical Centers

9.5.1 Overview

9.5.2 Ambulatory Surgical Centers: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

9.6 Others

9.6.1 Overview

9.6.2 Others: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

10. Europe Embolization Agents Market – Country Analysis

10.1 Europe: Embolization Agents Market

10.1.1 Overview

10.1.2 Europe: Embolization Agents Market, by Country, 2021 & 2028 (%)

10.1.2.1 Germany: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.1.1 Germany: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.1.2 Germany: Embolization Agents Market, by Product– Revenue and Forecast to 2028 (US$ Million)

10.1.2.1.2.1 Germany: Embolization Agents Market, by Coils– Revenue and Forecast to 2028 (USD Million)

10.1.2.1.2.2 Germany Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)

10.1.2.1.3 Germany: Embolization Agents Market, by Application – Revenue and Forecast to 2028 (US$ Million)

10.1.2.1.4 Germany: Embolization Agents Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.1.2.2 France: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.2.1 France: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.2.2 France: Embolization Agents Market, by Product – Revenue and Forecast to 2028 (US$ Million)

10.1.2.2.2.1 France: Embolization Agents Market, by Coils – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.2.2 France: Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.3 France: Embolization Agents Market, by Application – Revenue and Forecast to 2028 (US$ Million)

10.1.2.2.4 France: Embolization Agents Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.1.2.3 UK: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.3.1 UK: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.3.2 UK: Embolization Agents Market, by Product – Revenue and Forecast to 2028 (US$ Million)

10.1.2.3.2.1 UK: Embolization Agents Market, by Coils – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.2.2 UK: Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.3 UK: Embolization Agents Market, by Application – Revenue and Forecast to 2028 (US$ Million)

10.1.2.3.4 UK: Embolization Agents Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.1.2.4 Spain: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.4.1 Spain: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.4.2 Spain: Embolization Agents Market, by Product – Revenue and Forecast to 2028 (US$ Million)

10.1.2.4.2.1 Spain: Embolization Agents Market, by Coils – Revenue and Forecast to 2028 (USD Million)

10.1.2.4.3 Spain: Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)

10.1.2.4.4 Spain: Embolization Agents Market, by Application – Revenue and Forecast to 2028 (US$ Million)

10.1.2.4.5 Spain: Embolization Agents Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.1.2.5 Italy: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.5.1 Italy: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.5.2 Italy: Embolization Agents Market, by Product – Revenue and Forecast to 2028 (US$ Million)

10.1.2.5.2.1 Italy: Embolization Agents Market, by Coils – Revenue and Forecast to 2028 (USD Million)

10.1.2.5.2.2 Italy: Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)

10.1.2.5.3 Italy: Embolization Agents Market, by Application – Revenue and Forecast to 2028 (US$ Million)

10.1.2.5.4 Italy: Embolization Agents Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.1.2.6 Rest of Europe: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.6.1 Rest of Europe: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.6.2 Rest of Europe: Embolization Agents Market, by Product – Revenue and Forecast to 2028 (US$ Million)

10.1.2.6.2.1 Rest of Europe: Embolization Agents Market, by Coils – Revenue and Forecast to 2028 (USD Million)

10.1.2.6.2.2 Rest of Europe: Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)

10.1.2.6.3 Rest of Europe: Embolization Agents Market, by Application – Revenue and Forecast to 2028 (US$ Million)

10.1.2.6.4 Rest of Europe: Embolization Agents Market, by End User – Revenue and Forecast to 2028 (US$ Million)

11. Impact Of COVID-19 Pandemic on Europe Embolization Agents Market

11.1 Europe: Impact Assessment Of COVID-19 Pandemic

12. Europe Embolization Agents Market–Industry Landscape

12.1 Overview

12.2 Organic Developments

12.2.1 Overview

12.3 Inorganic Developments

12.3.1 Overview

13. Company Profiles

13.1 Medtronic

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 Terumo Corporation

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 Cook Medical LLC

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 Boston Scientific Corporation

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 Abbott

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Stryker Corporation

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 Penumbra, Inc.

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 Merit Medical Systems Inc.

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 DePuy Synthes

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

13.10 KANEKA CORPORATION

13.10.1 Key Facts

13.10.2 Business Description

13.10.3 Products and Services

13.10.4 Financial Overview

13.10.5 SWOT Analysis

13.10.6 Key Developments

14. Appendix

14.1 About The Insight Partners

14.2 Glossary of Terms

LIST OF TABLES

Table 1. Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ million)

Table 2. Germany: Embolization Agents Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 3. Germany: Embolization Agents Market, by Coils– Revenue and Forecast to 2028 (USD Million)

Table 4. Germany Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)

Table 5. Germany: Embolization Agents Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 6. Germany: Embolization Agents Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 7. France: Embolization Agents Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 8. France: Embolization Agents Market, by Coils – Revenue and Forecast to 2028 (USD Million)

Table 9. France: Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)

Table 10. France: Embolization Agents Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 11. France: Embolization Agents Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 12. UK: Embolization Agents Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 13. UK: Embolization Agents Market, by Coils – Revenue and Forecast to 2028 (USD Million)

Table 14. UK: Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)

Table 15. UK: Embolization Agents Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 16. UK: Embolization Agents Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 17. Spain: Embolization Agents Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 18. Spain: Embolization Agents Market, by Coils – Revenue and Forecast to 2028 (USD Million)

Table 19. Spain: Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)

Table 20. Spain: Embolization Agents Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 21. Spain: Embolization Agents Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 22. Italy: Embolization Agents Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 23. Italy: Embolization Agents Market, by Coils – Revenue and Forecast to 2028 (USD Million)

Table 24. Italy: Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)

Table 25. Italy: Embolization Agents Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 26. Italy: Embolization Agents Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 27. Rest of Europe: Embolization Agents Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 28. Rest of Europe: Embolization Agents Market, by Coils – Revenue and Forecast to 2028 (USD Million)

Table 29. Rest of Europe: Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)

Table 30. Rest of Europe: Embolization Agents Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 31. Rest of Europe: Embolization Agents Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 32. Organic Developments Done by Companies

Table 33. Inorganic Developments Done by Companies

Table 34. Glossary of Terms, Europe Embolization Agents Market

LIST OF FIGURES

Figure 1. Europe Embolization Agents Market Segmentation

Figure 2. Europe Embolization Agents Market Segmentation, By Country

Figure 3. Europe Embolization Agents Market Overview

Figure 4. Beads/ Particles Segment Held the Largest Share of the Product Segment in Europe Embolization Agents Market

Figure 5. UK to Show Significant Growth During Forecast Period

Figure 6. Europe and PEST Analysis

Figure 7. Europe Embolization Agents Market Impact Analysis of Drivers and Restraints

Figure 8. Europe Embolization Agents Market – Revenue Forecast and Analysis – 2020- 2028

Figure 9. Europe Embolization Agents Market Revenue Share, by Product (2021 and 2028)

Figure 10. Coils: Europe Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

Figure 11. Beads/Particles: Europe Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

Figure 12. Plugs: Europe Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

Figure 13. Detachable Balloons: Europe Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

Figure 14. Glue: Europe Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

Figure 15. Sponge: Europe Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

Figure 16. Liquid Embolics: Europe Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

Figure 17. Sclerosants: Europe Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

Figure 18. Precipitating Agents: Europe Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

Figure 19. Others: Europe Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

Figure 20. Europe Embolization Agents Market, by Application 2021 & 2028 (%)

Figure 21. Oncology: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22. Neurology: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23. Urology: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24. Cardiology: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25. Peripheral Vascular Diseases: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26. Others: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27. Europe Embolization Agents Market Revenue Share, By End User (2021 and 2028)

Figure 28. Hospitals: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29. Cardiac Centers: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30. Ambulatory Surgical Centers: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

Figure 31. Others: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

Figure 32. Europe: Embolization Agents Market, by Key Country – Revenue (2021) (USD Million)

Figure 33. Europe: Embolization Agents Market, by Country, 2021 & 2028 (%)

Figure 34. Germany: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

Figure 35. France: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

Figure 36. UK: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

Figure 37. Spain: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

Figure 38. Italy: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

Figure 39. Rest of Europe: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

Figure 40. Impact of COVID-19 Pandemic in European Country Markets

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe Embolization Agents Market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Europe Embolization Agents Market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the Embolization Agents Market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
Europe Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software and Serv..	May 2022
Europe Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Electric P..	May 2022
Europe In-Office Teeth Whitening Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Double-Syringe Mixing Configurat..	May 2022

Purchase Options

Single User License

$3000

$1800

Site License

$4000

$2400

Enterprise License

$5000